TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP

Institutional investor · Portfolio as of Q2 2023

SEC EDGAR SourceSEC Filings

Top Holdings2,967 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
QQQQQQ
Unit

INVESCO QQQ TRUST SERIES 1 CL USD INC

1.4M$505.8M1.3%$332.81+7.69%
18 qtrssince 2019-Q1
Increased
80
SPYSPY
Unit

STATE STREET SPDR S&P 500 ETF TRUST CL USD INC

1.1M$475.6M1.2%$408.09+3.98%
19 qtrssince 2018-Q4
Increased
80

NVIDIA CORP

693,906$293.5M0.7%$39.54+3.17%
2 qtrssince 2023-Q1
Increased
70

FORD MOTOR CO

17.8M$268.8M0.7%$10.19+21.58%
2 qtrssince 2023-Q1
Decreased
0

VISA INC-CLASS A SHARES

1.1M$261.5M0.7%$186.61+24.16%
17 qtrssince 2019-Q2
Decreased
0
QQQQQQ
CALL

INVESCO QQQ TRUST SERIES 1 CL USD INC

676,400$249.9M0.6%
New
QQQQQQ
PUT

INVESCO QQQ TRUST SERIES 1 CL USD INC

676,400$249.9M0.6%
New

ABBVIE INC

1.8M$247.5M0.6%$127.33-5.65%
3 qtrssince 2022-Q4
Increased
70

ANTHEM INC

555,940$247M0.6%$445.51-4.98%
3 qtrssince 2022-Q4
Increased
49

NEXTERA ENERGY INC

3.3M$242M0.6%

PAYPAL HOLDINGS INC

3.6M$241.5M0.6%$76.69-14.31%
8 qtrssince 2021-Q3
Increased
48

NIKE INC -CL B

2.2M$237.4M0.6%$108.170.00%
1 qtr
New
60

CARNIVAL CORP LTD

12.6M$237M0.6%$7.93+133.62%
3 qtrssince 2022-Q4
Decreased
0

WALMART INC

1.5M$233.9M0.6%$46.94+6.44%
3 qtrssince 2022-Q4
Decreased
0

CVS HEALTH CORPORATION

3.4M$232.3M0.6%$71.32-14.26%
7 qtrssince 2021-Q4
Increased
45

LOCKHEED MARTIN CORP

485,961$223.7M0.6%$391.48+9.10%
19 qtrssince 2018-Q4
Increased
70

HONEYWELL INTL INC

1.1M$221.1M0.6%$177.96+7.74%
19 qtrssince 2018-Q4
Decreased
0

COCA-COLA CO/THE

3.7M$220.1M0.6%$54.05+3.02%
4 qtrssince 2022-Q3
Increased
53

AMGEN INC

986,901$219.1M0.5%$205.05-1.25%
9 qtrssince 2021-Q2
Increased
45

THERMO FISHER SCIENTIFIC INC

419,834$219M0.5%$538.07-5.13%
3 qtrssince 2022-Q4
Increased
65
$39.9B
AUM
2,967
Positions
Q2 2023
Filing
Rating · 2.5
Quarterly Portfolio Change
-18%Q1'22$33.3B-11%Q2'22$29.7B-3%Q3'22$28.9B+7%Q4'22$31B+9%Q1'23$33.8B+11%Q2'23$37.4B
Activity profile
$ moved · Q2'23
New14%Increased45%Decreased33%Exited8%
Composition
Equity vs derivatives
Equity94%Puts5%Calls1%
Holding period
Avg 3.1 years
<1Q5%1-4Q9%1-2Y12%2Y+74%

TWO SIGMA INVESTMENTS, LP manages $39.9B across 2967 positions as of Q2 2023. Top holdings: QQQ (1.3%), SPY (1.2%), NVDA (0.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2.5/5.0.

Q2 2023 Summary

Active quarter - 515 new positions, 474 exits, 1119 increased. Top move: QQQ (INCREASED, conviction 80). Portfolio: $39.9B across 2967 positions.

Top holdings by portfolio weight

Total AUM$37B
QQQ1.27%
SPY1.19%
NEE0.84%
NVDA0.74%
F0.67%
V0.66%
ABBV0.62%
ELV0.62%
PYPL0.61%
NKE0.60%
Other0.59%

Portfolio allocation by GICS sector

Sectors11
Technology15.75%
Healthcare14.50%
Consumer Cyclical13.66%
Industrials12.11%
Unknown10.85%
Financial Services10.61%
Consumer Defensive6.51%
Basic Materials3.83%
Communication Services3.67%
Utilities3.26%
Other5.26%

Behavioral investing profile

Checking access…
Balanced Allocator- primarily Technology, Healthcare, Consumer Cyclical
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record51
Conviction38
Concentration12
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
8Q
AMTBAMTBAMERANT BANCORP INC
Q3 2024 Q2 2026+666,888 shares+$17.1M
8Q
ARCTARCTARCTURUS THERAPEUTICS HLDGS
Q3 2024 Q2 2026+1.1M shares+$7M
8Q
BCRXBCRXBIOCRYST PHARMACEUTICALS INC
Q3 2024 Q2 2026+5.1M shares+$57.4M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used